Nonsyndromic obesity is primarily associated with genetic mutations to factors involved in the leptin-melanocortin pathway and presents as a disruption to energy homeostasis and its monogenic form affects approximately 5% of the population with early-onset obesity (398-401). The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.